Antiepileptic Effect and Safety Profile of Rapamycin in Pediatric Patients With Tuberous Sclerosis Complex
BackgroundEpilepsy develops in 70–90% of children with Tuberous Sclerosis Complex (TSC) and is often resistant to medication. Treatment with mTOR pathway inhibitors is an important therapeutic option in drug-resistant epilepsy associated with TSC. Our study evaluated the antiepileptic effect of rapa...
Bewaard in:
| Hoofdauteurs: | , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2022-04-01
|
| Reeks: | Frontiers in Neurology |
| Onderwerpen: | |
| Online toegang: | https://www.frontiersin.org/articles/10.3389/fneur.2022.704978/full |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|